Fibroheal Woundcare Pvt Ltd has announced a successful funding round, raising an impressive ₹741,000 as it propels forward in revolutionizing the landscape of wound care management. Recognized under the aegis of Startup India and Startup Karnataka, Fibroheal is making waves with its unique approach to biomedical applications of silk proteins. This innovative startup has garnered accolades such as the National Technology Award in the startup category and substantial support from esteemed organizations, including the Department of Biotechnology (DBT) and the Center for Cellular and Molecular Platforms (CCAMP). The funds raised will be channeled into further research and development of bio-modified silk proteins, aimed at creating cutting-edge medical devices and solutions for advanced wound care management.
As a forerunner in addressing non-healing, slow-healing, and complex wounds, Fibroheal has developed a patented product that enhances scaffold formation and accelerates tissue regeneration, earning recognition from BIRAC for its innovation. The company’s mission is clear: to establish itself as a comprehensive wound care provider, harnessing the economic multiplier potential of silk proteins to significantly improve healing processes and outcomes for patients. By leveraging their scientific expertise and commitment to meaningful advancements, Fibroheal aims to not only enhance the quality of life for individuals suffering from challenging wounds but also to contribute to the broader healthcare ecosystem in India. With this funding, Fibroheal is poised to further its vision and continue making strides in the wound care arena, ensuring a brighter, healthier future for those in need.
